Shandong Boan Biotechnology Co (HKSE:06955) Other Financing: HK$-41.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06955 Shandong Boan Biotechnology Co Ltd HKSE:06955
42 GF Score
Price HK$2.93
GF Value HK$16.69
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Shandong Boan Biotechnology Co Other Financing?

Shandong Boan Biotechnology Co HKSE:06955 -5.33% 42 Other Financing is HK$-41.0 Mil as of Dec. 2025. GuruFocus rates HKSE:06955 with a GF Score™ of 42/100 and a GF Value™ of HK$16.69 (Possible Value Trap). The stock has 4 warning signs investors should review.

Shandong Boan Biotechnology Co's Other Financing for the six months ended in Dec. 2025 was HK$-20.0 Mil.

Shandong Boan Biotechnology Co's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-41.0 Mil.

Shandong Boan Biotechnology Co Other Financing Historical Data

* Premium members only.

The historical data trend for Shandong Boan Biotechnology Co's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Boan Biotechnology Co Other Financing Chart

Shandong Boan Biotechnology Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial 1,495.27 -249.76 204.83 -28.34 -41.17

Shandong Boan Biotechnology Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.14 224.80 -20.94 -20.01 0.00
HKSE:06955
42GF Score
Shandong Boan Biotechnology Co Ltd HKSE:06955
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Boan Biotechnology Co Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-41.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of HK$-41.0 Mil mean?
Shandong Boan Biotechnology Co (HKSE:06955) has a Other Financing of HK$-41.0 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Shandong Boan Biotechnology Co and its competitors.
Is Shandong Boan Biotechnology Co's Other Financing too high?
Shandong Boan Biotechnology Co's current Other Financing is HK$-41.0 Mil. Overall, Shandong Boan Biotechnology Co has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shandong Boan Biotechnology Co's Other Financing compare to VRTX and REGN?
Shandong Boan Biotechnology Co's Other Financing of HK$-41.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Shandong Boan Biotechnology Co and its competitors. Shandong Boan Biotechnology Co's current Other Financing is HK$-41.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Boan Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Boan Biotechnology Co (HKSE:06955) is currently considered Possible Value Trap. The stock's GF Value™ is HK$16.69, compared to a current price of HK$2.93 — trading 82.4% below its estimated fair value. The current Other Financing is HK$-41.0 Mil. Shandong Boan Biotechnology Co's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Shandong Boan Biotechnology Co (HKSE:06955), the current Other Financing is HK$-41.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Boan Biotechnology Co (HKSE:06955) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Boan Biotechnology Co stock appears to be undervalued. The current stock price of HK$2.93 is trading 82.4% below its estimated GF Value™ of HK$16.69. GuruFocus considers Shandong Boan Biotechnology Co to be Possible Value Trap.

Key valuation signals for HKSE:06955:

  • Other Financing: HK$-41.0 Mil
  • GF Value™: HK$16.69 vs. price of HK$2.93 (82.4% below fair value)
  • GF Score™: 42/100 with 4 warning signs

No single metric tells the full story. See the HKSE:06955 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shandong Boan Biotechnology Co Business Description

Address No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. It is focused on developing, manufacturing, and marketing biologics, with a focus on oncology, autoimmune diseases, ophthalmology, and metabolic diseases. The company's drug discovery activities revolve around multiple platforms: Fully Human Antibody Platform, bsAb/msAb/Probody Platform, and ADC Platform. It has commercialized several products, such as Boyounuo, Boyoubei (denosumab injection 60 mg), Boluojia (denosumab injection 120 mg), Boyouping (dulaglutide injection), and Boyoujing; and is actively engaged in the development of other drugs like BA1104 (nivolumab injection), BA1106, BA1302 (an anti-CD228 ADC), etc. Geographically, the company generates maximum revenue from the Chinese mainland.
42GF Score

Get the complete analysis for HKSE:06955

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.93
Price
HK$16.69
GF Value